Midatech Pharma Plc EV/Sales
Quel est le EV/Sales de Midatech Pharma Plc?
Le EV/Sales de Midatech Pharma Plc est N/A
Quelle est la définition de EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales des entreprises dans Health Care secteur sur LSE par rapport à Midatech Pharma Plc
Que fait Midatech Pharma Plc?
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Entreprises avec ev/sales similaire à Midatech Pharma Plc
- National Bank of Canada a EV/Sales de N/A
- Invesco Perpetual UK Smaller Companies Investment Trust Plc a EV/Sales de N/A
- B.N.Rathi Securities a EV/Sales de N/A
- Deutsche Bank AG a EV/Sales de N/A
- Midatech Pharma Plc a EV/Sales de N/A
- Alternative Liquidity Fund a EV/Sales de N/A
- Midatech Pharma Plc a EV/Sales de N/A
- Top 10 Split Trust a EV/Sales de N/A
- Oncternal Therapeutics a EV/Sales de N/A
- Pacific Horizon Investment Trust Plc a EV/Sales de N/A
- China Merchants China Direct Investments a EV/Sales de N/A
- JPMorgan Global Core Real Assests a EV/Sales de N/A
- Income Trust a EV/Sales de N/A